Qiagen N.v Stock News

We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.

PUNE, India, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Global Next Generation Sequencing (NGS) Market is growing with a CAGR of 17.1% in the forecast period of 2022 to 2029 and is expected to reach USD 29,307.13 Million by 2029. The most appropriate, exclusive, realistic, and admirable Next Generation Sequencing (NGS) Market Research Report is delivered with devotion depending upon the business needs. With the precise base year and the historic year, estimations and calculations are performed in this industry report. Market share analysis and key trend analysis are the key accomplishing factors in this market report. Report helps to recognize how the market is going to perform in the forecast years by giving information about market definition, classifications, applications, and engagements. DBMR team provides Next Generation Sequencing (NGS) Market research report with loyalty that is promising and the way in which expected. Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market Key Companies operating in the Next Generation Sequencing (NGS) Market are: Agilent Technologies Inc Thermo Fisher Scientific Inc QIAGEN Illumina Inc Bio-Rad Laboratories Inc Roche Sequencing (A subsidiary of F.

Thermo Fisher Scientific Inc., QIAGEN N.V. Quest Diagnostics,and Quidel Corp. are highlighted in this analyst blog.

Stocks like Thermo Fisher (TMO), QIAGEN (QGEN) and Quidel (QDEL) are expected to gain from increasing testing demand.

Stocks like Thermo Fisher (TMO), QIAGEN (QGEN) and Quidel (QDEL) are expected to gain from increasing testing demand.

Related Stocks: AZN , 8306 , 3092 , DPW , 086790 , BIRG , 9433 , SSE , ROG , ICLR , AMS , 4716 , BHP , QIA , 8697 , MAERSKB , 2301 , SRNG ,

Immuno Oncology Assays Market: An in-depth analysis of statistics on current and emerging trends provides clarity regarding Immuno Oncology Assays Market dynamics. The report includes Porter''s five forces to analyze the importance of various characteristics such as understanding of suppliers

The research reports on Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market report gives detailed overview of factors that affect global business scope. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market report shows the latest market

DUBLIN--(BUSINESS WIRE)--The "Bioinformatics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global bioinformatics market is expected to grow from $9.38 billion in 2020 to $10.57 billion in 2021 at a compound annual growth rate (CAGR) of 12.7%. The market is expected to reach $18.46 billion in 2025 at a CAGR of 15%. Major players in the bioinformatics market are Agilent Technologies, Illumina, QIAGEN, Affymetrix and

The investment arm of the Qatari state is bankrolling Rolls-Royces plans to build small modular nuclear reactors (SMRs). The Qatar Investment Authority (QIA) will invest £85m for 10% of the The post Qatar to invest in Rolls-Royces small nuclear reactor project appeared first on London Business News | Londonlovesbusiness.com .

The Qatar Investment Authority (QIA) has reached a deal with Rolls-Royce to invest in new small-scale nuclear power. The post Qatar takes Rolls-Royce small nuclear plans over the line appeared first on Energy Voice .

Rolls-Royce has reached agreement with Qatar Investment Authority (QIA), the sovereign wealth fund of the State of Qatar, to invest £85 million in Rolls-Royce SMR Limited. Rolls-Royce SMR is building a new technology solution to deliver affordable, low carbon, nuclear power. A single power station will occupy around one tenth of the size of a []

The latest financial backing will help the companys global growth strategy. Leading Dutch indoor farming startup Infarm is opening its first centre in Doha in 2023 following a massive $200 million financial backing from investors including the Qatar Investment Authority [QIA]. We see vertical farming as a way to enhance food security in every part [] (The post Dutch urban farming startup gets backing from Qatar wealth fund is from Doha News | Qatar .)

QIAGEN (NYSE:QGEN) has been assigned a consensus rating of Hold from the thirteen analysts that are covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among analysts that have issued [] The post QIAGEN (NYSE:QGEN) Given Average Rating of Hold by Analysts appeared first on ETF Daily News .